Histone deacetylases in hearing loss: Current perspectives for therapy

Hearing loss is one of the most frequent health issues in industrialized countries. The pathogenesis and molecular mechanisms of hearing loss are still unclear. Histone deacetylases (HDACs) are emerging as key enzymes in many physiological processes, including chromatin remodeling,regulation of tran...

Full description

Saved in:
Bibliographic Details
Published in:Journal of otology (Beijing) 2017-06, Vol.12 (2), p.47-54
Main Authors: Chen, Daishi, Xu, Ming, Wu, Beibei, Chen, Lei
Format: Article
Language:English
Subjects:
Cochlea
deacetylase
ear
HDAC
HDAC inhibitor
Hearing
Hearing loss
Histone
Histone deacetylase
inhibitor
Inner
Inner ear
loss
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hearing loss is one of the most frequent health issues in industrialized countries. The pathogenesis and molecular mechanisms of hearing loss are still unclear. Histone deacetylases (HDACs) are emerging as key enzymes in many physiological processes, including chromatin remodeling,regulation of transcription, DNA repair, metabolism, genome stability and protein secretion. Recent studies indicated that HDACs are associated with the development and progression of hearing loss. Dysfunction of HDACs could promote the oxidative stress and aging in the inner ear. In light of considering the current stagnation in the development of therapeutic options, the need for new strategies in the treatment of hearing loss has never been so pressing. In this review, we will summarize the reported literatures for HDACs in hearing loss and discuss how HDAC family members show different performances for the possibility of process of diseases development. The possibility of pharmacological intervention on hearing loss opens a novel path in the treatment of hearing loss.
ISSN:1672-2930
DOI:10.1016/j.joto.2017.04.002